Thyroid Dysfunction and Its Association With Metabolic Dysfunction-Associated Fatty Liver Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorTanta University
About this trial
This study aims to evaluate the prevalence of thyroid dysfunction and its association with metabolic dysfunction-associated fatty liver disease.
Eligibility criteria
Qualifiers
Age ≥ 18 years.
Both sexes.
Patients with metabolic dysfunction-associated fatty liver disease (MAFLD).
Disqualifiers
History of thyroid disease or treatment (e.g., thyroid nodules, thyroid cancer, hypothyroidism, and hyperthyroidism).
Patients with alcoholic liver disease take more than 40g of alcohol (or four units) per day.
Viral hepatitis.
Pregnant women.
Trial design
Treatments tested in this trial
- Fibroscan
Treatment groups
150 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov